5-[5-(5H-cyclopenta[b]pyridin-3-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(4,4-difluorocyclohexen-1-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;1-oxo-5-[5-(6-piperidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one;1-oxo-5-(4-pyridin-3-ylindazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-[5-(6-pyrrolidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one

C106H86F2N26O13S6 — CID 159224514

IUPAC5-[5-(5H-cyclopenta[b]pyridin-3-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(4,4-difluorocyclohexen-1-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;1-oxo-5-[5-(6-piperidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one;1-oxo-5-(4-pyridin-3-ylindazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-[5-(6-pyrrolidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one
SMILESCN1CCOc2cc(-c3ccc4c(cnn4C4=CC(=O)NS4=O)c3)cnc21.O=C1C=C(n2ncc3c(-c4cccnc4)cccc32)S(=O)N1.O=C1C=C(n2ncc3c(C4=CCC(F)(F)CC4)cccc32)S(=O)N1.O=C1C=C(n2ncc3cc(-c4ccc(N5CCCC5)nc4)ccc32)S(=O)N1.O=C1C=C(n2ncc3cc(-c4ccc(N5CCCCC5)nc4)ccc32)S(=O)N1.O=C1C=C(n2ncc3cc(-c4cnc5c(c4)CC=C5)ccc32)S(=O)N1
InChIInChI=1S/C20H19N5O2S.C19H17N5O2S.C18H15N5O3S.C18H12N4O2S.C16H13F2N3O2S.C15H10N4O2S/c26-19-11-20(28(27)23-19)25-17-6-4-14(10-16(17)13-22-25)15-5-7-18(21-12-15)24-8-2-1-3-9-24;25-18-10-19(27(26)22-18)24-16-5-3-13(9-15(16)12-21-24)14-4-6-17(20-11-14)23-7-1-2-8-23;1-22-4-5-26-15-7-12(9-19-18(15)22)11-2-3-14-13(6-11)10-20-23(14)17-8-16(24)21-27(17)25;23-17-8-18(25(24)21-17)22-16-5-4-11(6-14(16)10-20-22)13-7-12-2-1-3-15(12)19-9-13;17-16(18)6-4-10(5-7-16)11-2-1-3-13-12(11)9-19-21(13)15-8-14(22)20-24(15)23;20-14-7-15(22(21)18-14)19-13-5-1-4-11(12(13)9-17-19)10-3-2-6-16-8-10/h4-7,10-13H,1-3,8-9H2,(H,23,26);3-6,9-12H,1-2,7-8H2,(H,22,25);2-3,6-10H,4-5H2,1H3,(H,21,24);1,3-10H,2H2,(H,21,23);1-4,8-9H,5-7H2,(H,20,22);1-9H,(H,18,20)
InChIKeyKSCSCZKOEADBQZ-UHFFFAOYSA-N
MW2162.42 g/mol
LogP13.27
Rot. Bonds14

About 5-[5-(5H-cyclopenta[b]pyridin-3-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(4,4-difluorocyclohexen-1-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;1-oxo-5-[5-(6-piperidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one;1-oxo-5-(4-pyridin-3-ylindazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-[5-(6-pyrrolidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one

5-[5-(5H-cyclopenta[b]pyridin-3-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(4,4-difluorocyclohexen-1-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;1-oxo-5-[5-(6-piperidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one;1-oxo-5-(4-pyridin-3-ylindazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-[5-(6-pyrrolidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one (PubChem CID 159224514) has the molecular formula C106H86F2N26O13S6 and a molecular weight of 2162.42 g/mol. Its IUPAC name is 5-[5-(5H-cyclopenta[b]pyridin-3-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(4,4-difluorocyclohexen-1-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;1-oxo-5-[5-(6-piperidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one;1-oxo-5-(4-pyridin-3-ylindazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-[5-(6-pyrrolidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one.

Molecular Properties

Compound Name5-[5-(5H-cyclopenta[b]pyridin-3-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(4,4-difluorocyclohexen-1-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;1-oxo-5-[5-(6-piperidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one;1-oxo-5-(4-pyridin-3-ylindazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-[5-(6-pyrrolidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one
PubChem CID159224514
Molecular FormulaC106H86F2N26O13S6
Molecular Weight2162.42 g/mol
Exact Mass2160.52
IUPAC Name5-[5-(5H-cyclopenta[b]pyridin-3-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(4,4-difluorocyclohexen-1-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;1-oxo-5-[5-(6-piperidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one;1-oxo-5-(4-pyridin-3-ylindazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-[5-(6-pyrrolidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one
SMILESCN1CCOc2cc(-c3ccc4c(cnn4C4=CC(=O)NS4=O)c3)cnc21.O=C1C=C(n2ncc3c(-c4cccnc4)cccc32)S(=O)N1.O=C1C=C(n2ncc3c(C4=CCC(F)(F)CC4)cccc32)S(=O)N1.O=C1C=C(n2ncc3cc(-c4ccc(N5CCCC5)nc4)ccc32)S(=O)N1.O=C1C=C(n2ncc3cc(-c4ccc(N5CCCCC5)nc4)ccc32)S(=O)N1.O=C1C=C(n2ncc3cc(-c4cnc5c(c4)CC=C5)ccc32)S(=O)N1
InChIInChI=1S/C20H19N5O2S.C19H17N5O2S.C18H15N5O3S.C18H12N4O2S.C16H13F2N3O2S.C15H10N4O2S/c26-19-11-20(28(27)23-19)25-17-6-4-14(10-16(17)13-22-25)15-5-7-18(21-12-15)24-8-2-1-3-9-24;25-18-10-19(27(26)22-18)24-16-5-3-13(9-15(16)12-21-24)14-4-6-17(20-11-14)23-7-1-2-8-23;1-22-4-5-26-15-7-12(9-19-18(15)22)11-2-3-14-13(6-11)10-20-23(14)17-8-16(24)21-27(17)25;23-17-8-18(25(24)21-17)22-16-5-4-11(6-14(16)10-20-22)13-7-12-2-1-3-15(12)19-9-13;17-16(18)6-4-10(5-7-16)11-2-1-3-13-12(11)9-19-21(13)15-8-14(22)20-24(15)23;20-14-7-15(22(21)18-14)19-13-5-1-4-11(12(13)9-17-19)10-3-2-6-16-8-10/h4-7,10-13H,1-3,8-9H2,(H,23,26);3-6,9-12H,1-2,7-8H2,(H,22,25);2-3,6-10H,4-5H2,1H3,(H,21,24);1,3-10H,2H2,(H,21,23);1-4,8-9H,5-7H2,(H,20,22);1-9H,(H,18,20)
InChIKeyKSCSCZKOEADBQZ-UHFFFAOYSA-N
XLogP13.27
TPSA467.34 Ų
H-Bond Donors6
H-Bond Acceptors33
Rotatable Bonds14
Heavy Atoms153
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002162.42
LogP ≤ 513.27
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1033

Analyze 5-[5-(5H-cyclopenta[b]pyridin-3-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(4,4-difluorocyclohexen-1-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;1-oxo-5-[5-(6-piperidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one;1-oxo-5-(4-pyridin-3-ylindazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-[5-(6-pyrrolidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[5-(5H-cyclopenta[b]pyridin-3-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(4,4-difluorocyclohexen-1-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;1-oxo-5-[5-(6-piperidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one;1-oxo-5-(4-pyridin-3-ylindazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-[5-(6-pyrrolidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one?
The IUPAC name of 5-[5-(5H-cyclopenta[b]pyridin-3-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(4,4-difluorocyclohexen-1-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;1-oxo-5-[5-(6-piperidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one;1-oxo-5-(4-pyridin-3-ylindazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-[5-(6-pyrrolidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one (CID 159224514) is 5-[5-(5H-cyclopenta[b]pyridin-3-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(4,4-difluorocyclohexen-1-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;1-oxo-5-[5-(6-piperidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one;1-oxo-5-(4-pyridin-3-ylindazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-[5-(6-pyrrolidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one.
What is the SMILES notation for 5-[5-(5H-cyclopenta[b]pyridin-3-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(4,4-difluorocyclohexen-1-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;1-oxo-5-[5-(6-piperidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one;1-oxo-5-(4-pyridin-3-ylindazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-[5-(6-pyrrolidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one?
The canonical SMILES for 5-[5-(5H-cyclopenta[b]pyridin-3-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(4,4-difluorocyclohexen-1-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;1-oxo-5-[5-(6-piperidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one;1-oxo-5-(4-pyridin-3-ylindazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-[5-(6-pyrrolidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one is CN1CCOc2cc(-c3ccc4c(cnn4C4=CC(=O)NS4=O)c3)cnc21.O=C1C=C(n2ncc3c(-c4cccnc4)cccc32)S(=O)N1.O=C1C=C(n2ncc3c(C4=CCC(F)(F)CC4)cccc32)S(=O)N1.O=C1C=C(n2ncc3cc(-c4ccc(N5CCCC5)nc4)ccc32)S(=O)N1.O=C1C=C(n2ncc3cc(-c4ccc(N5CCCCC5)nc4)ccc32)S(=O)N1.O=C1C=C(n2ncc3cc(-c4cnc5c(c4)CC=C5)ccc32)S(=O)N1.
What is the InChIKey of 5-[5-(5H-cyclopenta[b]pyridin-3-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(4,4-difluorocyclohexen-1-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;1-oxo-5-[5-(6-piperidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one;1-oxo-5-(4-pyridin-3-ylindazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-[5-(6-pyrrolidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one?
The InChIKey is KSCSCZKOEADBQZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H19N5O2S.C19H17N5O2S.C18H15N5O3S.C18H12N4O2S.C16H13F2N3O2S.C15H10N4O2S/c26-19-11-20(28(27)23-19)25-17-6-4-14(10-16(17)13-22-25)15-5-7-18(21-12-15)24-8-2-1-3-9-24;25-18-10-19(27(26)22-18)24-16-5-3-13(9-15(16)12-21-24)14-4-6-17(20-11-14)23-7-1-2-8-23;1-22-4-5-26-15-7-12(9-19-18(15)22)11-2-3-14-13(6-11)10-20-23(14)17-8-16(24)21-27(17)25;23-17-8-18(25(24)21-17)22-16-5-4-11(6-14(16)10-20-22)13-7-12-2-1-3-15(12)19-9-13;17-16(18)6-4-10(5-7-16)11-2-1-3-13-12(11)9-19-21(13)15-8-14(22)20-24(15)23;20-14-7-15(22(21)18-14)19-13-5-1-4-11(12(13)9-17-19)10-3-2-6-16-8-10/h4-7,10-13H,1-3,8-9H2,(H,23,26);3-6,9-12H,1-2,7-8H2,(H,22,25);2-3,6-10H,4-5H2,1H3,(H,21,24);1,3-10H,2H2,(H,21,23);1-4,8-9H,5-7H2,(H,20,22);1-9H,(H,18,20).
What are the key properties of 5-[5-(5H-cyclopenta[b]pyridin-3-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(4,4-difluorocyclohexen-1-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;1-oxo-5-[5-(6-piperidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one;1-oxo-5-(4-pyridin-3-ylindazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-[5-(6-pyrrolidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one?
5-[5-(5H-cyclopenta[b]pyridin-3-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(4,4-difluorocyclohexen-1-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;1-oxo-5-[5-(6-piperidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one;1-oxo-5-(4-pyridin-3-ylindazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-[5-(6-pyrrolidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one has a molecular weight of 2162.42 g/mol, XLogP of 13.27, 14 rotatable bonds, 6 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[5-(5H-cyclopenta[b]pyridin-3-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[4-(4,4-difluorocyclohexen-1-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;5-[5-(4-methyl-2,3-dihydropyrido[3,2-b][1,4]oxazin-7-yl)indazol-1-yl]-1-oxo-1,2-thiazol-3-one;1-oxo-5-[5-(6-piperidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one;1-oxo-5-(4-pyridin-3-ylindazol-1-yl)-1,2-thiazol-3-one;1-oxo-5-[5-(6-pyrrolidin-1-yl-3-pyridinyl)indazol-1-yl]-1,2-thiazol-3-one is sourced from PubChem (CID 159224514), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).